Drug and Device Development – Drug and Device Digest

Drug and Device Development

Clinical Pharmacology Cards: JADENU, SYNJARDY

CLINICAL PHARMACOLOGY CARDS     Mechanism of Action   Orally active chelator that is selective for iron (as Fe3+) for the treatment of chronic iron overload due to blood transfusions. Pharmacodynamics (PD)         Deferasirox (10, 20,and 40 mg per kg per day) was able to induce a mean net iron excretion (0.119,… Continue reading Clinical Pharmacology Cards: JADENU, SYNJARDY

Scroll to Top